Skip to main content

Advertisement

SpringerLink
Log in

VEGF 936C>T polymorphism and breast cancer risk: evidence needed further clarification

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gu D, Wang M (2011) VEGF 936C>T polymorphism and breast cancer risk: evidence from 5, 729 cases and 5, 868 controls. Breast Cancer Res Treat 125:489–493

    Article  PubMed  CAS  Google Scholar 

  2. Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, Byrski T, Edler L, Lubinski J, Scott RJ, Hamann U (2008) The VEGF_936_C>T 3′UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women. Cancer Lett:71–76

  3. Pharoah PD, Tyrer J, Dunning AM, Easton DF, Ponder BA (2007) Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet 3:e42

    Article  PubMed  Google Scholar 

  4. Jakubowska A, Jaworska K, Cybulski C, Janicka A, Szymanska-Pasternak J, Lener M, Narod SA, Lubinski J (2009) Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? Eur J Cancer 45:837–842

    Article  PubMed  CAS  Google Scholar 

  5. Lin GT, Tseng HF, Yang CH, Hou MF, Chuang LY, Tai HT, Tai MH, Cheng YH, Wen CH, Liu CS, Huang CJ, Wang CL, Chang HW (2009) Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. OMICS 13:165–172

    Article  PubMed  CAS  Google Scholar 

References for Rebuttal Letter

  1. Pharoah PD, Tyrer J, Dunning AM, Easton DF, Ponder BA (2007) Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet 3:e42

    Article  PubMed  Google Scholar 

  2. Gu D, Wang M (2011) VEGF 936C>T polymorphism and breast cancer risk: evidence from 5, 729 cases and 5, 868 controls. Breast Cancer Res Treat 125:489–493

    Article  PubMed  CAS  Google Scholar 

  3. Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, Byrski T, Edler L, Lubinski J, Scott RJ, Hamann U (2008) The VEGF_936_C>T 3′UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women. Cancer Lett

  4. Jakubowska A, Jaworska K, Cybulski C, Janicka A, Szymanska-Pasternak J, Lener M, Narod SA, Lubinski J (2009) Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? Eur J Cancer 45:837–842

    Article  PubMed  CAS  Google Scholar 

  5. Lin GT, Tseng HF, Yang CH, Hou MF, Chuang LY, Tai HT, Tai MH, Cheng YH, Wen CH, Liu CS, Huang CJ, Wang CL, Chang HW (2009) Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. OMICS 13:165–172

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

All the authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Nan Chang University, 330006, Nanchang City, Jiangxi Province, China

    Liu Liu, Jia-Qing Cao & Pei-Qian Zhu

  2. Department of Anesthesiology, The Second Affiliated Hospital of Nan Chang University, 330006, Nanchang City, Jiangxi Province, China

    Fu-Zhou Hua

Authors
  1. Liu Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fu-Zhou Hua
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jia-Qing Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pei-Qian Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pei-Qian Zhu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, L., Hua, FZ., Cao, JQ. et al. VEGF 936C>T polymorphism and breast cancer risk: evidence needed further clarification. Breast Cancer Res Treat 127, 569–571 (2011). https://doi.org/10.1007/s10549-010-1339-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-010-1339-4

Keywords

Search

Navigation